Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:CEO |
gptkb:Dr._Nikolai_Petrovsky
|
| gptkbp:clinicalTrials |
Phase 1, Phase 2, Phase 3
Multiple vaccine trials |
| gptkbp:collaborations |
International pharmaceutical companies
|
| gptkbp:employees |
Approximately 50
|
| gptkbp:focusArea |
Infectious diseases
|
| gptkbp:foundedIn |
2007
|
| gptkbp:founder |
gptkb:Dr._Nikolai_Petrovsky
|
| gptkbp:headquarters |
gptkb:Adelaide,_Australia
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vaxine Pty Ltd
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:mission |
To develop innovative vaccines
|
| gptkbp:notableEvent |
gptkb:COVAX-19
|
| gptkbp:partnerships |
Various research institutions
|
| gptkbp:patentCitation |
Multiple patents on vaccine technology
|
| gptkbp:products |
Vaccines
|
| gptkbp:regulatoryCompliance |
TGA,_FDA
|
| gptkbp:research |
Government grants
|
| gptkbp:researchFocus |
Vaccine development
|
| gptkbp:technology |
Adjuvant technology
|
| gptkbp:vision |
To improve global health through vaccination.
|
| gptkbp:website |
www.vaxine.net
|